Home →
Resource →
Scale Loss Score (SLoS): a novel measure of drug benefit-risk assessment
Scale Loss Score (SLoS): a novel measure of drug benefit-risk assessment
https://www.ideas-itn.eu/wp-content/uploads/2018/06/Pavel_and_Gaelle_Poster_PSI_2018.pdf
pdf
Gaëlle Saint-Hilary, Veronique Robert, Mauro Gasparini & Pavel Mozgunov. PSI Conference 2018, Amsterdam and IBC 2018, Barcelona
Share this page
share using:
Or copy and paste this page address:
https://www.ideas-itn.eu/resources/scale-loss-score-slos-a-novel-measure-of-drug-benefit-risk-assessment/